- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/62 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving urea
Patent holdings for IPC class G01N 33/62
Total number of patents in this class: 98
10-year publication summary
|
12
|
5
|
7
|
7
|
5
|
8
|
2
|
5
|
9
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Labrador Diagnostics LLC | 268 |
9 |
| Roche Diagnostics Operations, Inc. | 1523 |
4 |
| Arizona Board of Regents on behalf of Arizona State University | 2965 |
4 |
| F. Hoffmann-La Roche AG | 7800 |
3 |
| Church & Dwight Co., Inc. | 1802 |
3 |
| Roche Diagnostics GmbH | 2684 |
2 |
| The Regents of the University of California | 20842 |
2 |
| Ajinomoto Co., Inc. | 2282 |
2 |
| Agency for Science, Technology and Research | 3753 |
2 |
| Duke University | 3186 |
2 |
| Aurinia Pharmaceuticals Inc. | 80 |
2 |
| Dignity Health | 492 |
2 |
| IDEXX Laboratories, Inc. | 911 |
2 |
| Prevencio, Inc. | 15 |
2 |
| Radiometer Medical ApS | 189 |
2 |
| Sierra Molecular Corporation | 5 |
2 |
| Vanda Pharmaceuticals, Inc. | 391 |
2 |
| Okayama Prefecture Industrial Promotion Foundation | 4 |
2 |
| Infagen (Hong Kong) Limited | 2 |
2 |
| The Procter & Gamble Company | 21859 |
1 |
| Other owners | 46 |